Here’s whether Elanco Animal Health Incorporated Common Stock (ELAN) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Neutral.
🔵
Neutral
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); strong 1-year return of +76.0%. Concerns: 50-day MA is falling (-0.58% over 10 days); RSI 77 — overbought, elevated pullback risk. Currently 14.8% off its 52-week high. Score: +2/7.
ELAN is in a confirmed uptrend, trading above both its 50-day ($22.88) and 200-day ($22.35) moving averages. With an RSI of 77.4, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +76.0% compares to +24.4% for SPY (beat the market by 51.6%).
$10,000 invested 1 year ago→ $17,595 today
vs. S&P 500 (SPY) — same period beat market by 51.6%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($22.35)
✓Above 50-day MA ($22.88)
!RSI(14) neutral zone (30–70) — currently 77.4
✓Positive return (+76.0%)
!Within 10% of period high (−14.8%)
Period Range $23.63
$13.16$27.72
RSI (14) 77.4
0 · OversoldOverbought · 100
Key Metrics
Price$23.63
Period Return+76.0%
Period High$27.72
Period Low$13.16
Drawdown−14.8%
MA-50$22.88
MA-200$22.35
RSI (14)77.4
Avg Volume (30d)7.0M
vs. SPYbeat by 51.6%
Return Rank#262 of 1245
Trend Signals
Price is above the 200-day moving average ($22.35)